Orion Pharma: Pioneering Life Science Innovation in Finland
Orion Pharma, a globally operating Finnish pharmaceutical company, is proud to join the LifeFactFuture (LFF) program, a unique collaboration aimed at advancing the Finnish life science industry. With a rich history dating back to 1917, Orion has been at the forefront of pharmaceutical innovation, developing, manufacturing, and marketing human and veterinary pharmaceuticals and active pharmaceutical ingredients.
Our Commitment to Innovation and Well-being
At Orion, we believe that health and well-being are the foundations of a good life and a thriving society. Our core therapy areas include oncology and pain management, where we continuously strive to develop new drugs and treatment methods. Our commitment to innovation is reflected in our close collaborations with healthcare professionals, leading global research institutions, and other pharmaceutical companies.
Driving Digital Transformation in Life Sciences
As part of the LFF program, Orion is dedicated to enhancing advanced pharmaceutical and life science manufacturing in Finland. The program aims to speed up the introduction of digital solutions and more efficient utilization of data, making Finland the most attractive place for investments in data-driven life science manufacturing. This initiative aligns perfectly with Orion’s strategy to leverage digital transformation for improved patient outcomes and operational efficiency.
Orion’s Parallel Project
In addition to our involvement in the LFF program, Orion has its own parallel project aiming to leverage new technologies and the opportunities offered by digitalization and data analytics, especially in enhancing data processing. The project’s goal is to better understand and control production processes and develop them by utilizing automation, new technologies, and effective data use.
The project consists of three key areas:
- Roadmap for Data Utilization
- Imaging Combined with AI Solutions
- Monitoring and Process Control
Collaborative Efforts for the Future
Orion’s participation in the LFF program highlights our ongoing commitment to innovation. By collaborating with other life science manufacturers, technology companies, and academic researchers, we aim to foster an ecosystem that supports the development of new technologies and practices. This collaboration is expected to create new opportunities and strengthen Finland’s position in the global life science industry.
Veera Kotiranta
Director, Operations Development at Orion Corporation
